ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
Dow Jones
37.815,92
-1,49%
Euro vs US Dollar
1,06541
-0,11%
Bitcoin
59.861,12
-1,22%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX
  6. Aptose Biosciences Inc (APS)

  7. Aptose Biosciences Inc (APS) News

APS

Aptose Biosciences (APS)

Aptose Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSX:APS
DatumZeitQuelleÜberschriftSymbolFirma
27/04/202017h02PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - APSTSX:APSAptose Biosciences Inc
27/04/202017h00PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - APSTSX:APSAptose Biosciences Inc
27/04/202016h59PR Newswire (Canada)IIROC Trade Resumption - APSTSX:APSAptose Biosciences Inc
27/04/202016h58PR Newswire (Canada)IIROC Trading Halt - APSTSX:APSAptose Biosciences Inc
29/12/201614h16PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - APSTSX:APSAptose Biosciences Inc
29/12/201614h15PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - APSTSX:APSAptose Biosciences Inc
29/12/201614h15PR Newswire (Canada)IIROC Trade Resumption - APSTSX:APSAptose Biosciences Inc
29/12/201614h13PR Newswire (Canada)IIROC Trading Halt - APSTSX:APSAptose Biosciences Inc
10/06/201523h00PR Newswire (US)Aptose Biosciences announces results of annual and special meeting of shareholdersTSX:APSAptose Biosciences Inc
10/06/201523h00PR Newswire (Canada)Aptose Biosciences announces results of annual and special meeting of shareholdersTSX:APSAptose Biosciences Inc
02/06/201520h00PR Newswire (US)Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid LeukemiaTSX:APSAptose Biosciences Inc
02/06/201520h00PR Newswire (Canada)Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid LeukemiaTSX:APSAptose Biosciences Inc
05/05/201522h15PR Newswire (US)Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015TSX:APSAptose Biosciences Inc
05/05/201522h15PR Newswire (Canada)Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015TSX:APSAptose Biosciences Inc
30/04/201514h00PR Newswire (US)Aptose Biosciences To Host First Quarter Ended March 31, 2015 Financial Results Conference Call and WebcastTSX:APSAptose Biosciences Inc
30/04/201514h00PR Newswire (Canada)Aptose Biosciences To Host First Quarter Ended March 31, 2015 Financial Results Conference Call and WebcastTSX:APSAptose Biosciences Inc
23/03/201513h30PR Newswire (US)Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory BoardTSX:APSAptose Biosciences Inc
23/03/201513h30PR Newswire (Canada)Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory BoardTSX:APSAptose Biosciences Inc
23/03/201513h00PR Newswire (US)Aptose Biosciences to Present at the 12th Annual BIO Asia International ConferenceTSX:APSAptose Biosciences Inc
23/03/201513h00PR Newswire (Canada)Aptose Biosciences to Present at the 12th Annual BIO Asia International ConferenceTSX:APSAptose Biosciences Inc
05/03/201514h00PR Newswire (Canada)Aptose Biosciences to Present at the 27th Annual ROTH ConferenceTSX:APSAptose Biosciences Inc
05/03/201514h00PR Newswire (US)Aptose Biosciences to Present at the 27th Annual ROTH ConferenceTSX:APSAptose Biosciences Inc
03/03/201522h30PR Newswire (US)Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014TSX:APSAptose Biosciences Inc
03/03/201522h30PR Newswire (Canada)Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014TSX:APSAptose Biosciences Inc
26/02/201514h00PR Newswire (US)Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and WebcastTSX:APSAptose Biosciences Inc
26/02/201514h00PR Newswire (Canada)Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and WebcastTSX:APSAptose Biosciences Inc
25/02/201522h39PR Newswire (US)Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare ConferenceTSX:APSAptose Biosciences Inc
25/02/201522h39PR Newswire (Canada)Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare ConferenceTSX:APSAptose Biosciences Inc
19/02/201514h00PR Newswire (Canada)Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare ConferenceTSX:APSAptose Biosciences Inc
19/02/201514h00PR Newswire (US)Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare ConferenceTSX:APSAptose Biosciences Inc
 Showing the most relevant articles for your search:TSX:APS

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
CCOM
US500
US 500
PM
XAUUSD
Gold vs US Dollar
COIN
SOLUSD
Solana
NASDAQ
GOOGL
Alphabet
USOTC
BASFY
BASF (QX)
TG
CBK
Commerzbank
NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
CCOM
SILVER
SILVER
TG
MBG
MercedesBenz
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten